A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTICCELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS
G. Franzoso et al., A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTICCELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS, The Journal of experimental medicine, 180(4), 1994, pp. 1445-1456
Two groups of U937 promonocytic cells were obtained by limiting diluti
on cloning which differed strikingly in their ability to support human
immunodeficiency virus 1 (HIV-1) replication. ''Plus'' clones replica
ted the virus efficiently, whereas ''minus'' clones did not. We examin
ed these clones for differences in nuclear factor (NF)-kappa B activit
y which might account for the observed phenomenon. Stimulation of plus
clones liberated the classical p50-p65 complex from cytoplasmic pools
, whereas minus clones produced an apparently novel, faster-migrating
complex, as judged by electrophoretic mobility shift assays. It is sur
prising that the faster-migrating complex was composed also of p50 and
p65. However, the p65 subunit was COOH-terminally truncated, as shown
by immunoprecipitation. The truncation resulted from limited proteoly
sis of p65 during cellular extraction which released particular lysoso
mal serine proteases, such as elastase, cathepsin G, and proteinase 3.
These specific proteases are coordinately expressed and were present
exclusively in the minus U937 clones, but not in the plus clones, as d
emonstrated in the case of cathepsin G. In addition, these proteases w
ere detected in certain subclones of THP-1 and HL-60 cells and in prim
ary monocytes, in each case correlating with the truncated form of p65
. We demonstrate in vitro cleavage of p65 by purified elastase and cat
hepsin G. It is possible that particular serine proteases may have inh
ibiting effects on the replication of HIV-1 in myelo-monocytic cells.
The data also demonstrate that special precautions must be taken when
making extracts from myelomonocytic cells.